Indication: Trelagliptin is used for the treatment of type 2 diabetes mellitus to improve blood sugar control in adults, usually in combination with diet and exercise.
Dosage:
Adults: 100 mg once weekly, taken orally.
Renal Impairment: Dose adjustment may be needed in severe cases.
Pediatric Use: Not established.
Content
Tab 50mg: Trelagliptin 50mg
Pregnancy
Only If Clearly Needed
Stability
Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
Contra Indications
Trelagliptin is contraindicated in patients with a history of hypersensitivity to the drug or any of its components. It should not be used in patients with type 1 diabetes, diabetic ketoacidosis, or severe renal impairment. Caution is advised in patients with liver disease or heart failure.
Precautions
Trelagliptin is contraindicated in patients with a history of hypersensitivity to the drug or any of its components. It should not be used in patients with type 1 diabetes, diabetic ketoacidosis, or severe renal impairment. Caution is advised in patients with liver disease or heart failure.
Lactation
Only If Necessary
Side Effects
Headache
Nausea
Dizziness
Upper respiratory tract infection
Hypoglycemia (when used with other antidiabetic drugs)